logo

Allogene Therapeutics Inc (ALLO) Stock: A Year of Market Movement, Down and Up

Examining a stock’s 52-week price history, encompassing its low and high prices, can reveal much about its existing condition and potential future trajectory. Allogene Therapeutics Inc’s current trading price is -67.53% away from its 52-week high, while its distance from the 52-week low is 42.05%. The stock’s price range over this period has fluctuated between $1.32 and $5.78. The company, operating within the financial sector, had a trading volume of approximately 1.21 million for the day, which was noticeably lower than the average daily share volume of 5.15 million over the last 3 months.

Allogene Therapeutics Inc ‘s stock market performance has been somewhat erratic. The company’s stock reached a 1-year high price of $5.78 on 03/08/24, while the lowest value for the same period was recorded at $1.32 on 02/12/25.

Exploring Financial Performance and Market Capitalization: A Comprehensive Analysis

Allogene Therapeutics Inc (ALLO) has experienced a quarterly decline of -17.76% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 393.13M and boasts a workforce of 233 employees.

Analyzing Trading Volume and Moving Average Trends

Based on Barchart.com data, the company’s moving average over the 100-day period was 2.2533, with a change in price of -0.7450. Similarly, Allogene Therapeutics Inc recorded 3,986,420 in trading volume during the last 100 days, posting a change of -28.54%.

Understanding Ticker ‘s Debt-to-Equity Ratio: An Analysis

The debt-to-equity (D/E) ratio serves as an important indicator of a company’s financial stability and market position. By dividing a company’s total liabilities by its shareholders’ equity, the D/E ratio reveals the degree to which a company relies on debt to finance assets compared to its shareholders’ equity. At the time of writing, the total D/E ratio for ALLO stands at 0.20. Similarly, the long-term debt-to-equity ratio is also 0.18.

ALLO Stock Stochastic Average

Today, Allogene Therapeutics Inc’s raw stochastic average for the past 50 days stands at 22.15%, indicating a rise from the raw stochastic average of the last 20 days, which was 22.15%. Moreover, the company’s Stochastic %K and %D values over the past 20 days were 25.68% and 27.62% respectively.

ALLO Stock Price Performance Analysis

The stock price’s performance over the year has been unpredictable, resulting in a mix of pessimistic and optimistic outlooks among investors. The index has shown a price loss of -11.97% this year. Over the last six months, there has been a stronger performance of -30.04%. The price of ALLO fallen by 1.90% during the last 30 days period. For the last 5-days stocks have slided -13.59%.

Most Popular